Stomach Cancer Trial, Recruiting (NCT04191551)

Stomach Cancer Trial, Recruiting NCT04191551 Sponsor: Stanford University Condition: Stomach Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT04191551 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Stomach Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People between the ages of 35 and 84 who are already scheduled for an outpatient endoscopy (a procedure to look inside the digestive tract)
People having that endoscopy for one of these specific reasons: abdominal pain, indigestion, low iron levels in the blood, testing for a stomach bacteria called Helicobacter pylori, monitoring of a known or suspected stomach lining condition called intestinal metaplasia, or checking for a family history of stomach cancer

Who may not be able to join:

People who are unable to give their own consent to take part in the trial
People who have had surgery on their stomach in the past
People who have a history of a solid tumour (a type of cancer) or who have had a bone marrow transplant
People whose blood does not clot normally — specifically, those with a platelet count below 70 or an INR (a measure of clotting) above 1.5 (confirm with trial site if unsure what these mean for a specific situation)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 26 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Robert J Huang, MD, Stanford University

Phone: 650-725-0634

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT04191551

Sponsor: Stanford University

Phase: Not Applicable

Status: Recruiting

Condition: Stomach Cancer

Trial contact: 650-725-0634

More information: https://clinicaltrials.gov/study/NCT04191551

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People between the ages of 35 and 84 who are already scheduled for an outpatient endoscopy (a procedure to look inside the digestive tract)
People having that endoscopy for one of these specific reasons: abdominal pain, indigestion, low iron levels in the blood, testing for a stomach bacteria called Helicobacter pylori, monitoring of a known or suspected stomach lining condition called intestinal metaplasia, or checking for a family history of stomach cancer

Who may not be able to join:

People who are unable to give their own consent to take part in the trial
People who have had surgery on their stomach in the past
People who have a history of a solid tumour (a type of cancer) or who have had a bone marrow transplant
People whose blood does not clot normally — specifically, those with a platelet count below 70 or an INR (a measure of clotting) above 1.5 (confirm with trial site if unsure what these mean for a specific situation)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 26 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Stanford University

Registry

ClinicalTrials.gov

Start date

30 July 2018

Est. completion

30 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Histologic Progression or Regression Assessed by OLGA Score; Histologic Progression or Regression Assessed by OLGIM Score; Development of Dysplasia; Development of Carcinoma

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov